Comparative Pharmacology
Head-to-head clinical analysis: ASCOR versus NASCOBAL.
Head-to-head clinical analysis: ASCOR versus NASCOBAL.
ASCOR vs NASCOBAL
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Ascorbic acid (vitamin C) acts as an antioxidant and a cofactor for several enzymes involved in collagen synthesis, carnitine biosynthesis, and neurotransmitter synthesis. It facilitates iron absorption from the gastrointestinal tract and participates in immune function.
Vitamin B12 (cyanocobalamin) is a cofactor for methionine synthase and methylmalonyl-CoA mutase, essential for DNA synthesis, myelin formation, and hematopoiesis.
1 tablet (75 mg) orally once daily for antiplatelet effect; for acute coronary syndrome: initial dose 300 mg orally, then 75 mg orally once daily.
1 spray (500 mcg) intranasally once weekly.
None Documented
None Documented
Clinical Note
moderateAscorbic acid + Cyclosporine
"The serum concentration of Cyclosporine can be decreased when it is combined with Ascorbic acid."
Clinical Note
moderateAscorbic acid + Bortezomib
"The therapeutic efficacy of Bortezomib can be decreased when used in combination with Ascorbic acid."
Clinical Note
moderateAscorbic acid + Benzphetamine
"The serum concentration of Benzphetamine can be decreased when it is combined with Ascorbic acid."
Clinical Note
moderateAscorbic acid + Amphetamine
Terminal elimination half-life is 8-12 hours in patients with normal renal function; prolonged to 24-48 hours in renal impairment, requiring dose adjustment.
Approximately 6 days (depot effect due to slow release from injection site); for intramuscular doses, terminal elimination half-life is about 6 days due to gradual absorption
Renal: 70-90% (as unchanged drug and metabolites), biliary/fecal: minor (<10%)
Primarily renal (60-80% as unchanged drug), biliary/fecal (5-10%)
Category C
Category C
Vitamin
Vitamin
"The serum concentration of Amphetamine can be decreased when it is combined with Ascorbic acid."